Tirzepamed (10) vials 20mg-100mg

Tirzepatide — New Zealand (10) vials.

Tirzepatide is a synthetic peptide commonly studied in scientific and laboratory research involving incretin receptor signaling, glucose metabolism, energy balance, and related endocrine pathways. It acts as a dual agonist at the GIP and GLP-1 receptors, making it of interest in metabolic and receptor-signaling research.

Designed for controlled research environments, Tirzepatide is supplied for analytical and experimental applications.

Key Features

• Synthetic peptide

• Dual GIP and GLP-1 receptor agonist

• Suitable for laboratory and analytical research

• Commonly studied in metabolic and endocrine research

• Relevant to incretin and glucose-regulation pathways

• Clearly labeled for research purposes

Important: This product is intended strictly for research purposes only. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention of any disease.